Europe Continuous Glucose Monitoring Systems Market is Expected to Reach $351.7 Million, by 2021

Europe Continuous Glucose Monitoring Systems Market Report, published by Allied Market Research, forecasts that the Europe market is expected to garner $351.7 million by 2021, registering a CAGR of 38.0% during the forecast period 2015 - 2021. Sensors segment is anticipated to generate the highest revenue in the European CGMS market during the forecast period.

For more details: https://www.alliedmarketresearch.com/europe-continuous-glucose-monitoring-systems-market

The European CGMS market is expected to witness dynamic growth, owing to increasing incidence rates of diabetes, growing per capita healthcare expenditure, and rising disposable income of individuals. In addition, CGMS offers various benefits over conventional glucose monitors such as higher precision, greater sensitivity, and periodic monitoring. CGMS technology is applicable in artificial/bionic pancreas; hence, several CGMS and insulin pump manufacturers focus on the development of novel and advanced CGMS. CGMS can be used across all age groups and various healthcare settings. However, unfavorable reimbursement policies for CGMS are expected to hamper the market growth.

Germany is the leading revenue-generating country, owing to favorable guidelines about pricing and fixed reimbursement budget allocation for CGMs devices. In addition, the European CGMS market is estimated to exhibit significant growth in Norway, Sweden, and Denmark due to advanced diabetes care facilities and robust clinical guidelines and standards for diabetes management.

Key findings of Europe Continuous Glucose Monitoring Systems Market:

• U.K. is projected to grow at the highest CAGR of 40.9% during the forecast period.
• Germany generated one-fourth of the total market revenue in 2015 and are projected to be the maximum revenue generating country till 2021.
• Sensors segment accounted for about two third of the market revenue in 2015 and are projected to exhibit prominent growth during the forecast period.
• U.K., Germany and France contributed over half of the market share in 2015.

For Customized Report: https://www.alliedmarketresearch.com/request-for-customization/862

Renowned companies, such as Senseonics and Rubin Medical, have adopted the collaboration strategy to commercialize their CGMS products in Denmark and Sweden. An Increasing number of diabetic patients, well-structured diabetes management regime, and proactive initiatives taken by the government have encouraged several CGMS companies to invest in Europe. Medtronic Inc., Dexcom, Inc., Abbott Diabetic care, Senseonics Incorporated, Insulet Corporation, Echo Therapeutics, Glysens Inc. and Animas Corporation are some of the prominent players in the European CGMS market.

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions". AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. The data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact
Pankaj Kumar
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Direct: +1-503-894-6022
Toll Free: +1 (800) 792-5285 (U.S. & Canada)
Fax: +1 (855) 550-5975
E-mail: sales@alliedmarketresearch.com
Website: https://www.alliedmarketresearch.com

This release was published on openPR.